scispace - formally typeset
S

Shizuo Akira

Researcher at Osaka University

Publications -  1330
Citations -  344469

Shizuo Akira is an academic researcher from Osaka University. The author has contributed to research in topics: Innate immune system & Immune system. The author has an hindex of 261, co-authored 1308 publications receiving 320561 citations. Previous affiliations of Shizuo Akira include University of California, Berkeley & Wakayama Medical University.

Papers
More filters
Journal ArticleDOI

Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance.

TL;DR: Evidence is provided for a role of the TRIF/IFN-β pathway in the regulation of lipid A/TLR4-mediated endotoxin homotolerance and for the involvement of TRIF and IFN regulatory factor 3 deficiency in tolerance.
Journal ArticleDOI

Crohn disease: A current perspective on genetics, autophagy and immunity

TL;DR: It is hoped that an improved understanding of pathogenic mechanisms, for example by studying the genetic basis of CD and other forms of inflammatory bowel diseases (IBD), will lead to improved therapies and possibly preventative strategies in individuals identified as being at risk.
Journal ArticleDOI

TRAF6 and MEKK1 Play a Pivotal Role in the RIG-I-like Helicase Antiviral Pathway *

TL;DR: TRAF6 is demonstrated to be critical for IFN-α/β induction in response to viral infection and intracellular double-stranded RNA, poly(I:C), and data suggest that IPS-1 requires TRAF6 and MEKK1 to activate NF-κB and mitogen-activated protein kinases that are critical for the optimal induction of type I interferons.
Journal ArticleDOI

Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.

TL;DR: It is suggested that estrogens inhibit IL-6 production by interfering with the function ofNF-kappaB rather than that of NF-IL6, suggesting that E2-induced conformational change of the hormone binding domain plays an important role in protein-protein interaction between ER and NF- kappaB.
Journal ArticleDOI

ZIP Kinase Triggers Apoptosis from Nuclear PML Oncogenic Domains

TL;DR: It is shown that ZIPK is present in PODs, where it colocalizes with and binds to proapoptotic protein Daxx, and mediates a novel nuclear pathway for apoptosis.